Loading stock data…
TWST
$90.27-2.17 (-2.35%)
Market ClosedLast close Jul 24
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Twist Bioscience Corporation in the Healthcare sector is trading at $90.27 with a market capitalization of $5.3B. Wall Street consensus targets $92.50 (10 analysts), implying a +2.5% move over the next 12 months. The stock is currently near its 52-week high of $105.47, remaining 76.5% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $110.72M↑ | $103.70M↑ | $99.01M↑ | $96.06M↑ | $92.79M |
| Gross Profit | $57.12M↑ | $53.97M↑ | $50.84M↓ | $51.30M↑ | $46.03M |
| Operating Income | -$38.66M↓ | -$33.10M↓ | -$29.93M↑ | -$30.12M↑ | -$41.56M |
| Net Income | -$44.02M↓ | -$30.51M↓ | -$27.14M↓ | $20.39M↑ | -$39.33M |
Peer Comparison
JNJUNHPFE
Fundamentals
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, an...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.33B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-17.86%
Volume
Today's trading volume
1.02M
Recent News
Twist Bioscience (TWST) Surged on Strong Results and AI Drug Discovery Demand
Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for its “Artisan Small Cap Fund”. A copy of the letter can be downloaded here. The fund reported strong absolute returns and modestly outperformed the Russell 2000® Growth Index, which gained 25.7%. Global equities rebounded as resilient US growth, moderating inflation, strong earnings and […]
Cathie Wood Dumps $39 Million Worth of AMD Stock
Cathie Wood Trims AMD to Fund Bigger SpaceX Bet
Cathie Wood Is Selling This High-Flying Stock. Is It a Buy?
Wood's ETFs sell stocks that have had strong runs to pay for other positions.
Cathie Wood’s ARK Invest Doubles Down On Circle In Two Funds At Once, Trims Robinhood Again
ARK's purchases come as investors closely watch progress on U.S. crypto legislation, including the CLARITY Act and stablecoin regulation efforts.
Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy?
Cathie Wood's Ark Genomic Revolution ETF owns $50 million worth of Recursion Pharmaceuticals stock.